Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Open Med Chem J
2010 Sep 03;4:57-61. doi: 10.2174/1874104501004010057.
Show Gene links
Show Anatomy links
A Single Amino Acid Substitution Makes WNK4 Susceptible to SB 203580 and SB 202190.
Glover M
,
Sweeny C
,
Davis B
,
O'Shaughnessy KM
.
???displayArticle.abstract???
Regulation of the SLC12 family of membrane transporters including NCCT involves a scaffold of interacting proteins including the STE 20 kinase SPAK and the WNK kinases, WNK 1 and WNK 4, which are mutated in the hypertensive syndrome of pseudohypoaldosteronism type 2 (PHAII). WNK4 regulates NCCT by affecting forward trafficking to the surface membrane. Studies in Xenopus using kinase dead WNK4 site mutants have produced inconsistent results with regard to the necessity of kinase function for NCCT regulation. Dynamic inhibition of WNK4 by small molecules may bring clarity to this issue however WNK4 is naturally resistant to commercial MAP kinase inhibitors owing to steric constraints prohibiting entry of small molecules to the active site. Using an approach similar to that used in p38 and ERK, we show that a single substitution in WNK4 (T261G) dramatically enhances its susceptibility to the inhibitors SB 202190 and SB 203580.
Fig. (1). Chemical structure of the p38 kinase inhibitors SB202190 and SB 203580.
Fig. (2). The T261G WNK4 mutant behaves like wild type WNK4.
A. Oocytes were injected with NCCT wt alone or in combination
with WNK4 wt or WNK4 T261G. Mutant WNK4 reduced 22Na+
flux equivalent to the same extent as WNK4 wt. * P< 0.0001vs
NCCT alone. B. Confocal microscopy of the fluorescent signal
from eCFP-NCCT showed that changes in WNK4 induced 22Na+
flux were accompanied by similar changes in surface membrane
expression of the cotransporter. * P< 0.0001 vs NCCT alone.
Fig. (3). The T261G mutation of WNK4 confers kinase inhibitor
sensitivity. A. Oocytes were injected with NCCT wt alone or in
combination with either WNK4 wt or WNK4 T261G. The 22Na+
flux assay was then performed with or without 0.5 or 5 µM of each
SB compound. * P<0.0001 vs NCCT alone. B. Confocal
microscopy of the fluorescent signal from eCFP-NCCT showed
that changes WNK4-induced 22Na+ flux were accompanied by
parallel changes in surface membrane expression of the
cotransporter. * P< 0.05 vs assay without an SB inhibitor.
Fig. (4). Concentration response curves showing reversal of WNK4
T261G inhibition of NCCT 22Na+ flux in Xenopus oocytes by (A)
SB 202190 and (B) SB203580. The fitted EC50 values
(concentration of inhibitor producing 50% reversal) were
respectively 147 and 109 nM.
Asano,
Role of phosphatidylinositol 3-kinase activation on insulin action and its alteration in diabetic conditions.
2007, Pubmed
Asano,
Role of phosphatidylinositol 3-kinase activation on insulin action and its alteration in diabetic conditions.
2007,
Pubmed
Bleeker,
AKT1(E17K) in human solid tumours.
2008,
Pubmed
Cohen,
The search for physiological substrates of MAP and SAP kinases in mammalian cells.
1997,
Pubmed
Cope,
WNK kinases and the control of blood pressure.
2005,
Pubmed
,
Xenbase
Cuenda,
Use of kinase inhibitors to dissect signaling pathways.
2000,
Pubmed
Deak,
Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB.
1998,
Pubmed
Disse-Nicodeme,
Genetic heterogeneity of familial hyperkalaemic hypertension.
2001,
Pubmed
Eyers,
Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution.
1998,
Pubmed
Fox,
A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
1998,
Pubmed
Gamba,
Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney.
1994,
Pubmed
,
Xenbase
Golbang,
A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene.
2005,
Pubmed
,
Xenbase
Golbang,
Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved.
2006,
Pubmed
,
Xenbase
Kahan,
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
2000,
Pubmed
Lee,
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis.
,
Pubmed
New,
PRAK, a novel protein kinase regulated by the p38 MAP kinase.
1998,
Pubmed
O'Brien,
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
2003,
Pubmed
O'Reilly,
Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo.
2006,
Pubmed
,
Xenbase
O'Reilly,
WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain.
2003,
Pubmed
Okuma-Yoshioka,
Tumor necrosis factor-alpha inhibits chondrogenic differentiation of synovial fibroblasts through p38 mitogen activating protein kinase pathways.
2008,
Pubmed
Tawara,
Progress of the study of rho-kinase and future perspective of the inhibitor.
2007,
Pubmed
Tong,
A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket.
1997,
Pubmed
Wilson,
Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4.
2003,
Pubmed
,
Xenbase
Wilson,
Human hypertension caused by mutations in WNK kinases.
2001,
Pubmed
Xu,
WNK1 activates SGK1 to regulate the epithelial sodium channel.
2005,
Pubmed
Yang,
Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport.
2005,
Pubmed
Zambrowicz,
Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.
2003,
Pubmed